Novartis raised its 2025 outlook, now expecting core profit to grow in the low teens, boosted by strong Q2 sales of key drugs like breast cancer treatment Kisqali.
We use cookies to give you the best possible browsing experience. By continuing to use the website, you consent to the use of cookies. You may withdraw your consent at any time - see our Cookie Policy for further details.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.